Global Orthopedic Surgery Bone Cements Market Growth 2026-2032
Description
The global Orthopedic Surgery Bone Cements market size is predicted to grow from US$ 840 million in 2025 to US$ 1290 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
Orthopedic Surgery Bone Cements are sterile surgical cements used to secure orthopedic implants and reinforce weakened bone, most often in hip and knee arthroplasty as well as vertebral augmentation. The product scope covers medical grade acrylic resin bone cement systems sold as finished kits, including antibiotic loaded versions and delivery systems that are sold together with the cement as one commercial unit.
Upstream supply relies on medical grade polymer powder, monomer, radiopacifier, and controlled initiator and activator chemistry, with optional antibiotic additives that must satisfy pharmaceutical quality expectations while preserving cement performance. These inputs exist widely in industrial supply chains, but converting them into medical products depends on sterile packaging, validated bioburden control, lot traceability, and defensible regulatory documentation, which raises entry barriers. Downstream demand is concentrated in hospital operating rooms and spine centers, where purchasing typically flows through centralized hospital procurement, group purchasing organizations, or regional tender platforms. Typical industry gross margin is around 25 to 35 percent, with a central tendency near 30 percent, supported by compliance requirements, clinical risk exposure, validated sterilization and packaging, and strong surgeon and hospital standardization once a cement system is qualified.
In the current market, global production is around 23215 K Units, with an average selling price of about 37 USD per Unit EXW basis. Competition is moderately concentrated, with leading multinational suppliers holding strong positions in premium arthroplasty and revision settings, while regional producers gain share in tender focused markets by meeting baseline quality and supply requirements at lower price points. Demand remains most concentrated in North America and Europe for arthroplasty and revisions, while China and the broader Indo Pacific are increasingly influenced by tender execution, expanded procedure access, and more standardized clinical pathways. Unit volumes are expected to rise with aging demographics, deeper arthroplasty penetration, and continued treatment of vertebral compression fractures, while pricing faces persistent pressure as centralized procurement expands and antibiotic stewardship narrows indications for antibiotic loaded products. Key constraints include regulatory timelines for formulation changes, the need to keep handling and clinical outcomes consistent across batches, and the difficulty of scaling sterile supply without degrading quality metrics.
LP Information, Inc. (LPI) ' newest research report, the “Orthopedic Surgery Bone Cements Industry Forecast” looks at past sales and reviews total world Orthopedic Surgery Bone Cements sales in 2025, providing a comprehensive analysis by region and market sector of projected Orthopedic Surgery Bone Cements sales for 2026 through 2032. With Orthopedic Surgery Bone Cements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orthopedic Surgery Bone Cements industry.
This Insight Report provides a comprehensive analysis of the global Orthopedic Surgery Bone Cements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopedic Surgery Bone Cements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orthopedic Surgery Bone Cements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopedic Surgery Bone Cements and breaks down the forecast by Antibiotic Load, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopedic Surgery Bone Cements.
This report presents a comprehensive overview, market shares, and growth opportunities of Orthopedic Surgery Bone Cements market by product type, application, key manufacturers and key regions and countries.
Segmentation by Antibiotic Load:
Plain
Gentamicin Loaded
Tobramycin Loaded
Dual or Other Antibiotic
Segmentation by Viscosity:
Low Viscosity
Medium Viscosity
High Viscosity
Segmentation by Form Factor:
Two-Component Powder plus Monomer
Pre-Filled Cartridge or Syringe Kit
Integrated Mixing and Delivery System
Segmentation by Application:
Arthroplasty Fixation
Vertebral Augmentation
Posterior Screw Augmentation
Cranio Maxillofacial and Neuro
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
KYERON
Stryker
Djo Surgical
Depuy Synthes
Globus Medical
Zimmer Biomet
Exactech
AMPLITUDE
Aditus Medical
Teknimed
Groupe Lépine
Tecres
BPB MEDICA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orthopedic Surgery Bone Cements market?
What factors are driving Orthopedic Surgery Bone Cements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orthopedic Surgery Bone Cements market opportunities vary by end market size?
How does Orthopedic Surgery Bone Cements break out by Antibiotic Load, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Orthopedic Surgery Bone Cements are sterile surgical cements used to secure orthopedic implants and reinforce weakened bone, most often in hip and knee arthroplasty as well as vertebral augmentation. The product scope covers medical grade acrylic resin bone cement systems sold as finished kits, including antibiotic loaded versions and delivery systems that are sold together with the cement as one commercial unit.
Upstream supply relies on medical grade polymer powder, monomer, radiopacifier, and controlled initiator and activator chemistry, with optional antibiotic additives that must satisfy pharmaceutical quality expectations while preserving cement performance. These inputs exist widely in industrial supply chains, but converting them into medical products depends on sterile packaging, validated bioburden control, lot traceability, and defensible regulatory documentation, which raises entry barriers. Downstream demand is concentrated in hospital operating rooms and spine centers, where purchasing typically flows through centralized hospital procurement, group purchasing organizations, or regional tender platforms. Typical industry gross margin is around 25 to 35 percent, with a central tendency near 30 percent, supported by compliance requirements, clinical risk exposure, validated sterilization and packaging, and strong surgeon and hospital standardization once a cement system is qualified.
In the current market, global production is around 23215 K Units, with an average selling price of about 37 USD per Unit EXW basis. Competition is moderately concentrated, with leading multinational suppliers holding strong positions in premium arthroplasty and revision settings, while regional producers gain share in tender focused markets by meeting baseline quality and supply requirements at lower price points. Demand remains most concentrated in North America and Europe for arthroplasty and revisions, while China and the broader Indo Pacific are increasingly influenced by tender execution, expanded procedure access, and more standardized clinical pathways. Unit volumes are expected to rise with aging demographics, deeper arthroplasty penetration, and continued treatment of vertebral compression fractures, while pricing faces persistent pressure as centralized procurement expands and antibiotic stewardship narrows indications for antibiotic loaded products. Key constraints include regulatory timelines for formulation changes, the need to keep handling and clinical outcomes consistent across batches, and the difficulty of scaling sterile supply without degrading quality metrics.
LP Information, Inc. (LPI) ' newest research report, the “Orthopedic Surgery Bone Cements Industry Forecast” looks at past sales and reviews total world Orthopedic Surgery Bone Cements sales in 2025, providing a comprehensive analysis by region and market sector of projected Orthopedic Surgery Bone Cements sales for 2026 through 2032. With Orthopedic Surgery Bone Cements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orthopedic Surgery Bone Cements industry.
This Insight Report provides a comprehensive analysis of the global Orthopedic Surgery Bone Cements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopedic Surgery Bone Cements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orthopedic Surgery Bone Cements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopedic Surgery Bone Cements and breaks down the forecast by Antibiotic Load, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopedic Surgery Bone Cements.
This report presents a comprehensive overview, market shares, and growth opportunities of Orthopedic Surgery Bone Cements market by product type, application, key manufacturers and key regions and countries.
Segmentation by Antibiotic Load:
Plain
Gentamicin Loaded
Tobramycin Loaded
Dual or Other Antibiotic
Segmentation by Viscosity:
Low Viscosity
Medium Viscosity
High Viscosity
Segmentation by Form Factor:
Two-Component Powder plus Monomer
Pre-Filled Cartridge or Syringe Kit
Integrated Mixing and Delivery System
Segmentation by Application:
Arthroplasty Fixation
Vertebral Augmentation
Posterior Screw Augmentation
Cranio Maxillofacial and Neuro
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
KYERON
Stryker
Djo Surgical
Depuy Synthes
Globus Medical
Zimmer Biomet
Exactech
AMPLITUDE
Aditus Medical
Teknimed
Groupe Lépine
Tecres
BPB MEDICA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orthopedic Surgery Bone Cements market?
What factors are driving Orthopedic Surgery Bone Cements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orthopedic Surgery Bone Cements market opportunities vary by end market size?
How does Orthopedic Surgery Bone Cements break out by Antibiotic Load, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
120 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Orthopedic Surgery Bone Cements by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Orthopedic Surgery Bone Cements by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
